RAD50 and acute myeloid leukemia: Likewise, genomic alterations may disrupt many pathways at once; for instance, Simonetti et al. [27] observed high levels of PLK1, an overexpression of CDC20, and, along with RAD50, a three gene signature for AML, which indicates a multistep process involving different cell cycle phases.